Member Info for PlantPower

Evening - sharing respected poster from Telegram chat:

“ Emailed David Budd on this point. He confimed they are not in the LDT (lab designed test) group thats now had its EUA application cancelled with no more allowed. They are in the manufacturing high output section. He said this move would take pressure off the FDA.”

“ Basically what happened is every university and capable diagnostics lab globally has been developing their own assays for Covid19.”

“ All capable and potentially worthwhile research and all have been asking for FDA EUA.”

“ FDA have cancelled the progression of hundreds of these.”

“ And are now concentrating on only the ones (like ours) that can make a difference”

PP

DrM - what’s your point chap?

People aren’t allowed to top up?

People don’t have revenue streams or additional funds which allows them to continue to build a position (small or big) over time?

Do you think by stating investment intentions we are trying to manipulate the market??

What’s your point doc?

PP

Nice work bigAl - currently freeing up some US funds to take advantage of these levels tomorrow.

PP

Looks like PEEL still offloading - steadfast on ASK in the face of BUY strength showing on BID/ASK as multiple all day.

What do they have on their books?!? BGF still??? Other??

Tomorrow’s delayed trades will be interesting.

PP

Apologies - GDR are explicitly mentioned in print ??

Totally agreed Technik - all short term traders trying to time their entry and then bailing when doesn’t materialise, as you say, good luck if you can trade successfully whilst still catching the monster wave!

103 psid

102.8 paid..

LP Personally - I’m pleased it’s delayed, my moneys on they know they’ll at least have a material BC update by then and as you say, good chance we may have an approval or 2.

If trading update today, without either of above, SP would tank (short term).

https://www.biopharma-reporter.com/Article/2020/10/29/COVID-19-testing-will-remain-key-even-as-vaccines-enter-into-the-fray-says-Cytiva-as-it-invests-in-diagnostic-inventory-and-service-labs

GDR not explicitly mentioned but interesting take on testing need

Snippet from presentation on twitter:

https://twitter.com/keya5000/status/1321552315166457856?s=21

Me too Midsummer on both counts - good luck

Hi @midsummer - not largely significant except showing big demand still there when snippets of news flow start surfacing, which is encouraging as when material SP will shift significantly.

Reckon circa 355k buys at 1st quick check out of circa 630k vol - so not all buys, but did include one 200k vol in one hit for 120p

PP

Magsy - that was startling and reassuring, sure history will look back on the failure of efficient and effective approvals, whilst still maintaining robustness, rigour and due diligence as major shortcoming.

Not something to be solved now, but clearly demonstrates underfunding, budgeting and preparedness for such an outbreak - appreciate easy being an after timer, but we have to learn from past mistakes and look/rake back over with critical lense.

Anyhow, as you say, reaffirms for non believers that there is are critical external dependencies preventing DB expecting on strategy (which couldn’t have been foreseen), that said, DB has no excuses not to be ready and execute once approvals land.

Still expecting judgement to be positive come d-day - macro climate is worsening from humanity perspective but global market crying out for diagnostic products, (unfortunately), this is firmly the market to be in and GDR should flourish.

PP

Allah - as pleasant as it’s been having you on the board this month, fancy taking November off?

More from telegram:

“ Budd sounded assured and confident. He was talking with the air of a man who had the right to sit at a top table. I.e he gave the impression he had delivered something superb and he was so proud of such. They had grouped together overcame supply chain issues delivered in a short period of time etc.

He’s either going to deliver in spades or get an equity card.”

“ Question you must ask if he’s achieved nothing why did Cytiva want him on the panel?”

The industry guys had been saying they see mass population testing to be the next step. Fast POC that don’t have PCR aspect aren’t the answer. They work on days 3 onwards post infection best. That leaves a gap when they are infectious but the rapid POC wouldnt pick it up. So if you think thats an answer to the problem in its entirety you are wrong. Rapid PCR is the only way.“

“ Agree. He needs to deliver. He wasn’t sat there though or was invited by Cytiva due to running a failing outfit for the last six months.”

Copied from telegram chat - wasn’t on call:

“In the chat, they made note that FDA are inundated with approvals. Some 2600 submissions but antigens are being prioritised.”

Reckon circa 355k buys at 1st quick check

Circa 630k vol delayed vol from yesterday just printed - haven’t gone through buys vs sells yet

Apologies - meant yesterday delayed trade, notice they often get executed / printed around 5-510pm.

Anyhow, good seeing tick up again.